EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort

Anushika Raheja iD, Kexin Ang iD, Bernett Lee iD, Seyed Ehsan Saffari iD, Eng King Tan, Crystal Jing Jing Yeo iD

Muscle & Nerve · 2026-12 · 74 (6) · 1611-1618

DOI: 10.1002/mus.70427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 12.10.2026. Verfasst von Anushika Raheja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore, Singapore. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Science, Technology and Research (A*STAR), National Neuroscience Institute Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Data from Asian cohorts on whether statin therapy affects amyotrophic lateral sclerosis (ALS) progression are limited. We examined whether statin exposure was associated with ALS disease duration or tracheostomy‐free survival in a multiethnic Asian ALS cohort.

Methods

Data from patients diagnosed with ALS between 2012 and 2025 were retrospectively reviewed. Patients were categorized as “ever” or “never” statin users for primary analyses, and as “never,” “former,” or “current” users at diagnosis for additional analyses. Disease duration was defined as time from symptom onset to death, and tracheostomy‐free survival as time from symptom onset to tracheostomy or death without tracheostomy. Kaplan–Meier and Cox regression analyses evaluated associations between statin exposure and both outcomes. Additional analyses examined statin discontinuation after diagnosis using time‐varying exposures. Sensitivity analyses excluded post‐diagnosis imitators and applied 30‐, 90‐, and 180‐day lags.

Results

Among 103 ALS patients, 27 (26.2%) had ever received statins. Statin exposure was not significantly associated with disease duration (hazard ratio [HR]: 1.42, 95% CI: 0.64–3.14, p = 0.387) or tracheostomy‐free survival (HR: 1.04, 95% CI: 0.50–2.18, p = 0.913). Post‐diagnosis statin discontinuation was associated with shorter survival in a time‐varying analysis (HR: 6.52, 95% CI: 1.48–28.74, p = 0.013), although this finding was hypothesis‐generating. Sensitivity analyses did not show statistically significant associations.

Discussion

In this multiethnic Asian ALS cohort, statin exposure was not significantly associated with disease duration or tracheostomy‐free survival. These findings add to the evidence that statins do not need to be discontinued due to ALS diagnosis. Larger studies are needed to define this association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHydroxymethylglutaryl-CoA Reductase InhibitorsAgedFemaleHumansMaleMiddle AgedAsian PeopleCohort StudiesDisease ProgressionRetrospective Studies

Stichwörter der Autor:innen

Asiaamyotrophic lateral sclerosisdisease progressionstatinssurvival analysis

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore, Singapore.
  • Department of Neurology, National Neuroscience Institute (Tan Tock Seng Campus), Singapore, Singapore.
  • Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Centre for Biomedical Informatics, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research A*STAR, Singapore, Singapore.
  • Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

ORCID-Profile: Anushika Raheja, Kexin Ang, Bernett Lee, Seyed Ehsan Saffari, Crystal Jing Jing Yeo

Förderung

  • Agency for Science, Technology and Research (A*STAR)
  • National Neuroscience Institute Singapore

Zitieren

APA

Raheja, A., Ang, K., Lee, B., Saffari, S. E., Tan, E. K., & Yeo, C. J. J. (2026). Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort. Muscle & Nerve, 74(6), 1611-1618. https://doi.org/10.1002/mus.70427

Vancouver

Raheja A, Ang K, Lee B, Saffari SE, Tan EK, Yeo CJJ. Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort. Muscle & Nerve. 2026;74(6):1611-1618. doi:10.1002/mus.70427

BibTeX
@article{Raheja2026,
  author = {Raheja, Anushika and Ang, Kexin and Lee, Bernett and Saffari, Seyed Ehsan and Tan, Eng King and Yeo, Crystal Jing Jing},
  title = {Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {1611--1618},
  doi = {10.1002/mus.70427}
}
Kostenlos starten →